The examples and perspective in this article deal primarily with the United States and do not represent a worldwide view of the subject. (November 2017) (Learn how and when to remove this template message)
Mylanta is a brand of over-the-counter drugs for digestive problems, manufactured by Infirst Healthcare USA under license from McNeil Consumer Healthcare, a division of Johnson & Johnson (formerly Pfizer since 2007 following its acquisition). It includes several different products intended to treat heartburn and bloating.
Recall and availability
In November 2010 Mylanta was voluntarily recalled due to what is described as some labelling concerns. According to sources within the company at that time, these concerns stemmed from the fact that small traces of alcohol were found in the flavoring agents of the liquid version of the antacid which was not disclosed on the labelling itself, and that the problem would be rectified "shortly". Generic liquid antacids comparable to Mylanta are now available (e.g., under the brand name "equaline" among others).
Mylanta was reintroduced to the market in 2016.
- "News | Mylanta". November 29, 2010. Archived from the original on December 3, 2010.
- "LABEL: EQUALINE ANTACID- aluminum hydroxide, magnesium hydroxide, simethicone suspension". DailyMed.
- "Mylanta heartburn remedy returns to stores". June 7, 2016.